{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T07:41:37Z","timestamp":1775893297898,"version":"3.50.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>The diagnosis of neurosarcoidosis (NS) remains challenging due to the difficulty to obtain central nervous system (CNS) biopsies. Various diagnostic parameters are considered for the definition of possible, probable and definite NS. Magnetic resonance imaging (MRI) is the imaging gold standard and considered in diagnostic criteria. Fluorodeoxyglucose positron emission (<jats:sup>18<\/jats:sup>F-FDG PET) is sometimes performed additionally to identify possible systemic biopsy targets. However, at present, its findings are not incorporated into the diagnostic criteria for neurosarcoidosis (NS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a single center retrospective search for the period 2020\u20132022, for patients with neurological symptoms in a diagnostic context of suspected NS who underwent MRI and additional <jats:sup>18<\/jats:sup>F-FDG PET scans to identify potential hypermetabolism in the CNS and biopsy targets.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified three cases of NS, where Gadolinium-enhanced MRI scans did not show abnormalities while <jats:sup>18<\/jats:sup>F-FDG PET revealed hypermetabolic lesions in areas of the CNS. Additional MRI scans were still inconclusive for structural changes. We diagnosed a \u201cprobable\u201d NS in all cases with histopathological confirmation of systemic sarcoidosis which led to an intensified therapy regime.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p><jats:sup>18<\/jats:sup>F-FDG PET is an early indicator for metabolic changes. It appears to be a useful add-on to improve accuracy of diagnostic criteria in suspected NS without MRI findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42466-023-00299-9","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:02:36Z","timestamp":1706140956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reevaluating the relevance of 18F-FDG PET findings for diagnosis of neurosarcoidosis: a case series"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4355-4121","authenticated-orcid":false,"given":"Jessy","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Furth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Bohner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Siffrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"299_CR1","first-page":"e1084","volume":"8","author":"MJ Bradshaw","year":"2021","unstructured":"Bradshaw, M. J., Pawate, S., Koth, L. L., Cho, T. A., & Gelfand, J. M. (2021). Neurosarcoidosis. Pathophysiology, Diagnosis, and Treatment, 8, e1084.","journal-title":"Pathophysiology, Diagnosis, and Treatment"},{"key":"299_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/WCO.0000000000000684","volume":"32","author":"M Voortman","year":"2019","unstructured":"Voortman, M., Drent, M., & Baughman, R. P. (2019). Management of neurosarcoidosis: A clinical challenge. Current Opinion in Neurology, 32, 475\u2013483.","journal-title":"Current Opinion in Neurology"},{"key":"299_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clineuro.2012.03.042","volume":"115","author":"S Bartels","year":"2013","unstructured":"Bartels, S., Kyavar, L., Blumstein, N., et al. (2013). FDG PET findings leading to diagnosis of neurosarcoidosis. Clinical Neurology and Neurosurgery, 115, 85\u201388.","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"299_CR4","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1212\/WNL.0b013e3182684672","volume":"79","author":"JF Huang","year":"2012","unstructured":"Huang, J. F., Aksamit, A. J., & Staff, N. P. (2012). MRI and PET imaging discordance in neurosarcoidosis. Neurology, 79, 1070\u20131070.","journal-title":"Neurology"},{"key":"299_CR5","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1212\/NXI.0000000000000506","volume":"5","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Andrews, J., Jenkins Colon, P., & Wundes, A. (2018). FDG-PET abnormalities leading to the diagnosis of an unusual case of probable neurosarcoidosis. Neurology - Neuroimmunology Neuroinflammation, 5, e506.","journal-title":"Neurology - Neuroimmunology Neuroinflammation"},{"key":"299_CR6","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","volume":"75","author":"BJ Stern","year":"2018","unstructured":"Stern, B. J., Royal, W., III., Gelfand, J. M., et al. (2018). Definition and consensus diagnostic criteria for neurosarcoidosis: From the neurosarcoidosis consortium consensus group. JAMA Neurology, 75, 1546\u20131553.","journal-title":"JAMA Neurology"},{"key":"299_CR7","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.mayocp.2020.01.032","volume":"95","author":"D Fritz","year":"2020","unstructured":"Fritz, D., van de Beek, D., Brouwer, M. C., & Booij, J. (2020). Whole-body 18F-FDG PET-CT in the diagnosis of neurosarcoidosis. Mayo Clinic Proceedings, 95, 1082\u20131084.","journal-title":"Mayo Clinic Proceedings"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-023-00299-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-023-00299-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-023-00299-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:03:45Z","timestamp":1706141025000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurolrespract.biomedcentral.com\/articles\/10.1186\/s42466-023-00299-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":7,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["299"],"URL":"https:\/\/doi.org\/10.1186\/s42466-023-00299-9","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"31 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Applicable. Ethics approval was obtained (EA2_260_22). All patients consented to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients were informed about case series publication and signed a consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}